Envestnet Asset Management Inc. Sells 1,245 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Envestnet Asset Management Inc. cut its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 2.7% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 44,942 shares of the company’s stock after selling 1,245 shares during the period. Envestnet Asset Management Inc.’s holdings in Henry Schein were worth $3,078,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of HSIC. Palestra Capital Management LLC bought a new stake in shares of Henry Schein in the fourth quarter valued at about $182,988,000. Lyrical Asset Management LP acquired a new position in shares of Henry Schein during the 4th quarter worth approximately $126,655,000. Norges Bank acquired a new position in shares of Henry Schein during the 4th quarter worth approximately $103,301,000. Steadfast Capital Management LP increased its position in shares of Henry Schein by 254.2% during the 4th quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company’s stock worth $113,336,000 after purchasing an additional 1,175,408 shares during the last quarter. Finally, Hudson Bay Capital Management LP increased its position in shares of Henry Schein by 102.1% during the 4th quarter. Hudson Bay Capital Management LP now owns 1,465,007 shares of the company’s stock worth $101,378,000 after purchasing an additional 740,007 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Stock Performance

NASDAQ:HSIC opened at $71.46 on Monday. The stock has a market cap of $8.70 billion, a P/E ratio of 22.33, a PEG ratio of 2.31 and a beta of 0.87. The company has a quick ratio of 0.75, a current ratio of 1.38 and a debt-to-equity ratio of 0.50. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The business’s 50-day moving average price is $71.90 and its two-hundred day moving average price is $71.39.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. The company had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. Henry Schein’s revenue for the quarter was down .1% compared to the same quarter last year. During the same period last year, the firm posted $1.10 EPS. As a group, equities analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently issued reports on HSIC. Evercore ISI increased their target price on Henry Schein from $72.00 to $78.00 and gave the stock an “in-line” rating in a report on Wednesday, July 9th. Leerink Partners set a $75.00 target price on Henry Schein in a report on Monday, July 14th. Stifel Nicolaus restated a “hold” rating and set a $75.00 price objective (down previously from $80.00) on shares of Henry Schein in a report on Friday. Baird R W downgraded Henry Schein from a “strong-buy” rating to a “hold” rating in a report on Monday, July 14th. Finally, Robert W. Baird restated a “neutral” rating and issued a $72.00 price objective (down previously from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Nine equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, Henry Schein has an average rating of “Hold” and an average target price of $78.08.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.